BioMarin Restructures, Outlines Roadmap To $4B Revenues By 2027 - Biomarin Pharmaceutical ( NASDAQ:BMRN )

2 weeks ago

BioMarin Pharmaceutical Inc BMRN plans to land $4 billion in revenue by 2027. The company is targeting an adjusted operating margin of low-to-mid 40%'s ( starting at 40% in 2026 ) . The new structure, announced at an investor event Wednesday, covers three key business units.

Ticker	Sentiment	Impact
BMRN	Neutral	24 %